----

----

| Nevada                         |   | 59-3486297          |
|--------------------------------|--------|---------------------|
| State or other jurisdiction of |   | (I.R.S. Employer    |
| Incorporation or organization  |   | Identification No.) |

| Large accelerated filer                       | o      | Accelerated filer         | o |
|-----------------------------------------------|--------|---------------------------|---|
| Non-accelerated filer                         | þ | Smaller reporting company | o |
| (Do not check if a smaller reporting company) |

----

----

----

|                                                                                                                                                                     | June 30, |   | December 31, |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------|--------|--------------|--------|
|                                                                                                                                                                     | 2012     |   | 2011         |   |
| ASSETS                                                                                                                                                                   |     |   |         |   |   |   |
|                                                                                                                                                                     |     |   |         |   |   |   |
| Current assets:                                                                                                                                                          |     |   |         |   |   |   |
| Cash and cash equivalents                                                                                                                                                |     | $      | 4,402        |   |   | $ | 2,693 |   |
| Trade accounts receivable (net of allowance for doubtful accounts of  $39 and $44 at June 30, 2012 and December 31, 2011, respectively)                        |     |   | 5,551        |   |   |   | 4,155 |   |
| Inventories, net                                                                                                                                                         |     |   | 11,255       |   |   |   | 12,148 |   |
| Deferred tax assets                                                                                                                                                      |     |   | 2,966        |   |   |   | 3,458 |   |
| Prepaid expenses and other current assets                                                                                                                                |     |   | 982          |   |   |   | 526 |   |
| Total current assets                                                                                                                                                     |     |   | 25,156       |   |   |   | 22,980 |   |
| Property, plant and equipment, net                                                                                                                                       |     |   | 1,096        |   |   |   | 1,158 |   |
| Deferred tax assets, net                                                                                                                                                 |     |   | 4,712        |   |   |   | 4,712 |   |
| Capitalized software, net                                                                                                                                                |     |   | 2,337        |   |   |   | 2,778 |   |
| Other assets                                                                                                                                                             |     |   | 201          |   |   |   | 219 |   |
| Total assets                                                                                                                                                             |     | $      | 33,502       |   |   | $ | 31,847 |   |
|                                                                                                                                                                     |     |   |         |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' EQUITY                                                                                                                                     |     |   |         |   |   |   |   |   |
|                                                                                                                                                                     |     |   |         |   |   |   |   |   |
| Current liabilities:                                                                                                                                                     |     |   |         |   |   |   |   |   |
| Accounts payable                                                                                                                                                         |     | $      | 2,162        |   |   | $ | 1,756 |   |
| Accrued compensation and related taxes                                                                                                                                   |     |   | 1,204        |   |   |   | 807 |   |
| Accrued warranty expense                                                                                                                                                 |     |   | 243          |   |   |   | 247 |   |
| Accrued other expenses and other current liabilities                                                                                                                     |     |   | 195          |   |   |   | 318 |   |
|       Note payable                                                                                                                         |     |   | 53           |   |   |   | - |   |
|      Deferred revenue                                                                                                                           |     |   | 558          |   |   |   | 385 |   |
| Total current liabilities                                                                                                                                                |     |   | 4,415        |   |   |   | 3,513 |   |
|                                                                                                                                                                     |     |   |         |   |   |   |   |   |
| Deferred revenue                                                                                                                                                         |     |   | 133          |   |   |   | 265 |   |
| Long-term debt                                                                                                                                                           |     |   | -            |   |   |   | - |   |
| Total liabilities                                                                                                                                                        |     | $      | 4,548        |   |   | $ | 3,778 |   |
| Commitments and contingencies                                                                                                                                            |     |   |         |   |   |   |   |   |
| Stockholders' equity:                                                                                                                                                    |     |   |         |   |   |   |   |   |
| Preferred stock; $1.00 par value; 1,000,000 authorized shares none issued or outstanding.                                                                                |     |   | -            |   |   |   | - |   |
| Common stock; $.60 par value; 20,000,000 authorized shares: 13,545,482 and 13,519,323 issued and outstanding shares at June 30, 2012 and December 31, 2011, respectively |     |   | 8,127        |   |   |   | 8,111 |   |
| Additional paid-in capital                                                                                                                                               |     |   | 24,594       |   |   |   | 24,570 |   |
| Accumulated deficit                                                                                                                                                      |     |   | (3,767       | )      |   |   | (4,612 | ) |
| Total stockholders' equity                                                                                                                                               |     |   | 28,954       |   |   |   | 28,069 |   |
| Total liabilities and stockholders' equity                                                                                                                               |     | $      | 33,502       |   |   | $ | 31,847 |   |

----

|                                        |   | Three Months Ended |       |   | Six months Ended |   |
|---------------------------------------------|--------|--------------------|------------|--------|------------------|--------|
|                                        |   | June 30,2012       |       |   | June 30,2011     |   |   | June 30,2012 |   |   | June 30,2011 |   |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |
| Sales, net                                  |   | $                  | 9,327      |   |             | $      | 4,671 |   |   | $ | 13,696 |   |   | $ | 11,385 |   |
| Expenses                                    |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Cost of products                            |   |               | 4,687      |   |             |   | 3,015 |   |   |   | 7,389 |   |   |   | 7,128 |   |
| Selling, general and administrative         |   |               | 2,624      |   |             |   | 2,484 |   |   |   | 4,964 |   |   |   | 5,732 |   |
| Total expenses                              |   |               | 7,311      |   |             |   | 5,499 |   |   |   | 12,353 |   |   |   | 12,860 |   |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Operating income (loss)                     |   |               | 2,016      |   |             |   | (828 | ) |   |   | 1,343 |   |   |   | (1,475 | ) |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Other expense:                              |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net interest expense                        |   |               | (3         | )      |             |   | (27 | ) |   |   | (3 | ) |   |   | (62 | ) |
| Other expense                               |   |               | (2         | )      |             |   | - |   |   |   | (7 | ) |   |   | (6 | ) |
| Total other expense                         |   |               | (5         | )      |             |   | (27 | ) |   |   | (10 | ) |   |   | (68 | ) |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
|  Income (loss) before income taxes     |   |               | 2,011      |   |             |   | (855 | ) |   |   | 1,333 |   |   |   | (1,543 | ) |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Income tax expense                          |   |               | (765       | )      |             |   | - |   |   |   | (488 | ) |   |   | - |   |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net income (loss)                           |   | $                  | 1,246      |   |             | $      | (855 | ) |   | $ | 845 |   |   | $ | (1,543 | ) |
|                                        |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Net earnings (loss) per share-basic:        |   | $                  | 0.09       |   |             | $      | (0.06 | ) |   | $ | 0.06 |   |   | $ | (0.11 | ) |
| Net earnings (loss) per share-diluted:      |   | $                  | 0.09       |   |             | $      | (0.06 | ) |   | $ | 0.06 |   |   | $ | (0.11 | ) |
| Weighted average shares outstanding-basic   |   |               | 13,544,273 |   |             |   | 13,508,815 |   |   |   | 13,539,111 |   |   |   | 13,508,815 |   |
| Weighted average shares outstanding-diluted |   |               | 13,545,141 |   |             |   | 13,508,815 |   |   |   | 13,540,851 |   |   |   | 13,508,815 |   |

----

|                                                                                                  |   | Six months Ended |   |
|-------------------------------------------------------------------------------------------------------|--------|------------------|--------|
|                                                                                                  |   | June 30,2012     |   |   | June 30,2011 |   |
|                                                                                                  |   |             |   |   |   |   |
| Operating activities                                                                                  |   |             |   |   |   |   |
| Net income (loss)                                                                                     |   | $                | 845    |   |   | $ | (1,543 | ) |
| Adjustments to reconcile net loss to net cash  provided by operating activities:            |   |             |   |   |   |   |   |   |
| Allowance for doubtful accounts                                                                       |   |             | (5     | ) |   |   | - |   |
| Inventories reserve                                                                                   |   |             | (21    | ) |   |   | 52 |   |
| Deferred tax obligation                                                                               |   |             | 492    |   |   |   | - |   |
| Depreciation and amortization                                                                         |   |             | 641    |   |   |   | 704 |   |
| Shared-based compensation expense                                                                     |   |             | 18     |   |   |   | 91 |   |
| Changes in operating assets and liabilities:                                                          |   |             |   |   |   |   |   |   |
| Accounts receivable                                                                                   |   |             | (1,391 | ) |   |   | 1,372 |   |
| Inventories                                                                                           |   |             | 914    |   |   |   | (1,102 | ) |
| Prepaid expenses and other current assets                                                             |   |             | (456   | ) |   |   | 90 |   |
| Other assets                                                                                          |   |             | 18     |   |   |   | 23 |   |
| Accounts payable                                                                                      |   |             | 406    |   |   |   | (826 | ) |
| Accrued compensation and related taxes                                                                |   |             | 397    |   |   |   | 38 |   |
| Accrued warranty expense                                                                              |   |             | (4     | ) |   |   | 20 |   |
| Note payable                                                                                          |   |             | 53     |   |   |   | - |   |
| Deferred revenue                                                                                      |   |             | 41     |   |   |   | 192 |   |
| Accrued other expenses and other current liabilities                                                  |   |             | (123   | ) |   |   | (46 | ) |
| Net cash  provided by (used in ) operating activities                                       |   |             | 1,825  |   |   |   | (935 | ) |
|                                                                                                  |   |             |   |   |   |   |   |   |
| Investing activities                                                                                  |   |             |   |   |   |   |   |   |
| Purchases of property, plant and equipment                                                            |   |             | (138   | ) |   |   | (181 | ) |
| Net cash used in investing activities                                                                 |   |             | (138   | ) |   |   | (181 | ) |
|                                                                                                  |   |             |   |   |   |   |   |   |
| Financing activities                                                                                  |   |             |   |   |   |   |   |   |
| Proceeds from issuance of common stock                                                                |   |             | 22     |   |   |   | - |   |
| Increase in revolving line of credit                                                                  |   |             | -      |   |   |   | 1,500 |   |
| Decrease in revolving line of credit                                                                  |   |             | -      |   |   |   | (1,200 | ) |
| Cash provided by financing activities                                                                 |   |             | 22     |   |   |   | 300 |   |
|                                                                                                  |   |             |   |   |   |   |   |   |
|                                                                                                  |   |             |   |   |   |   |   |   |
| Net change in cash and cash equivalents                                                               |   |             | 1,709  |   |   |   | (816 | ) |
| Cash and cash equivalents, beginning of period                                                        |   |             | 2,693  |   |   |   | 5,050 |   |
| Cash and cash equivalents, end of period                                                              |   | $                | 4,402  |   |   | $ | 4,234 |   |
|                                                                                                  |   |             |   |   |   |   |   |   |
| Supplemental disclosure                                                                               |   |             |   |   |   |   |   |   |
| Cash paid for interest                                                                                |   | $                | 3      |   |   | $ | 62 |   |
| Income tax paid                                                                                       |   | $                | 62     |   |   | $ | - |   |
| Non-cash financing activity                                                                           |   |             |   |   |   |   |   |   |
| Cashless exercise of stock options and related conversion of net shares to stockholders’ equity |   | $                | 4      |   |   | $ | - |   |

----

----

|            |   | June 30,2012 |   |   | December 31,2011 |   |
|-----------------|--------|--------------|--------|--------|------------------|--------|
| Finished goods  |   | $            | 3,326  |   |             | $      | 3,981 |   |
| Work in process |   |         | 4,638  |   |             |   | 4,671 |   |
| Raw materials   |   |         | 3,291  |   |             |   | 3,496 |   |
|            |   | $            | 11,255 |   |             | $      | 12,148 |   |

----

|                                    |   | Common Stock Shares |       |   | Common Stock Amount |   |    | Additional Paid-In Capital |   |   | Accumulated Deficit |   |   | Total  |    |
|-----------------------------------------|--------|---------------------|------------|--------|---------------------|--------|---------|----------------------------|--------|--------|---------------------|--------|--------|--------|---------|
|                                    |   |                |       |   |                |   |    |                       |   |   |                |   |   |   |    |
| Balance at December 31, 2011            |   |                | 13,519,323 |   |                | $      | 8,111   |                       |   | $      | 24,570              |   |   | $      | (4,612  | ) |   | $ | 28,069 |   |
| Common stock option exercise and issued |   |                | 26,159     |   |                |   | 16      |                       |   |   | 6                   |   |   |   |    |   |   |   | 22 |   |
| Share-based compensation expense   |   |                | −    |   |                |   | − |                       |   |   | 18                  |   |   |   | − |   |   |   | 18 |   |
| Net income                              |   |                | −    |   |                |   | − |                       |   |   | −             |   |   |   | 845     |   |   |   | 845 |   |
| Balance at June 30, 2012                |   |                | 13,545,482 |   |                | $      | 8,127   |                       |   | $      | 24,594              |   |   | $      | (3,767  | ) |   | $ | 28,954 |   |

----

|                                                                              |   | Three Months Ended |       |   | Six Months Ended |   |
|-----------------------------------------------------------------------------------|--------|--------------------|------------|--------|------------------|--------|
|                                                                              |   | June 30, 2012      |       |   | June 30, 2011    |   |   | June 30, 2012 |   |   | June 30, 2011 |   |
| Numerator:                                                                        |   |               |       |   |             |   |   |   |   |   |   |   |
| Net  income (loss) (numerator for basic and diluted earnings per share) |   | $                  | 1,246      |   |             | $      | (855 | ) |   | $ | 845 |   |   | $ | (1,543 | ) |
|                                                                              |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Denominator:                                                                      |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Denominator for basic earnings per share weighted average shares                  |   |               | 13,544,273 |   |             |   | 13,508,815 |   |   |   | 13,539,111 |   |   |   | 13,508,815 |   |
|                                                                              |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Effect of dilutive securities:                                                    |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
|        Options                                 |   |               | 868        |   |             |   | - |   |   |   | 1,740 |   |   |   | - |   |
|                                                                              |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Denominator                                                                       |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Denominator for diluted earnings per share weighted average shares                |   |               | 13,545,141 |   |             |   | 13,508,815 |   |   |   | 13,540,851 |   |   |   | 13,508,815 |   |
|                                                                              |   |               |       |   |             |   |   |   |   |   |   |   |   |   |   |   |
| Basic income (loss) per share                                                     |   | $                  | 0.09       |   |             | $      | (0.06 | ) |   | $ | 0.06 |   |   | $ | (0.11 | ) |
| Diluted income (loss) per share                                                   |   | $                  | 0.09       |   |             | $      | (0.06 | ) |   | $ | 0.06 |   |   | $ | (0.11 | ) |

----

| As of April 1, 2012 |   | Stock Options |    |   | Wgt. Avg. ExercisePrice ($)Per Share |   |   | Wgt. Avg. Remaining Contractual Life (Years) |   |   | Wgt. Avg. Grant Date Fair Value($)Per Share |   |   | Aggregate IntrinsicValue ($) |   |
|---------------------|--------|---------------|---------|--------|--------------------------------------|--------|--------|----------------------------------------------|--------|--------|---------------------------------------------|--------|--------|------------------------------|--------|
|                |   |          |    |   |                                 |   |   |                                         |   |   |                                        |   |   |                         |   |
| Outstanding         |   |          | 503,444 |   |                                 |   | 3.53   |                                         |   |   | -                                           |   |   |                         | 2.30   |   |   |   | - |   |
| Vested              |   |          | 473,444 |   |                                 |   | 3.63   |                                         |   |   | -                                           |   |   |                         | 2.40   |   |   |   | - |   |
| Nonvested           |   |          | 30,000  |   |                                 |   | 2.00   |                                         |   |   | -                                           |   |   |                         | 0.61   |   |   |   | - |   |
|                |   |          |    |   |                                 |   |   |                                         |   |   |                                        |   |   |                         |   |   |   |   |   |   |
| Period activity     |   |          |    |   |                                 |   |   |                                         |   |   |                                        |   |   |                         |   |   |   |   |   |   |
| Issued              |   |          | 25,000  |   |                                 |   | 2.03   |                                         |   |   | -                                           |   |   |                         | 0.68   |   |   |   | - |   |
| Exercised           |   |          | 2,500   |   |                                 |   | 0.88   |                                         |   |   | -                                           |   |   |                         | 0.62   |   |   |   | - |   |
| Forfeited           |   |          | -       |   |                                 |   | -      |                                         |   |   | -                                           |   |   |                         | -      |   |   |   | - |   |
| Expired             |   |          | 60,000  |   |                                 |   | 5.52   |                                         |   |   | -                                           |   |   |                         | 2.28   |   |   |   | - |   |
|                |   |          |    |   |                                 |   |   |                                         |   |   |                                        |   |   |                         |   |   |   |   |   |   |
| As of June 30, 2012 |   |          |    |   |                                 |   |   |                                         |   |   |                                        |   |   |                         |   |   |   |   |   |   |
| Outstanding         |   |          | 495,944 |   |                                 |   | 3.43   |                                         |   |   | 4.60                                        |   |   |                         | 2.24   |   |   |   | 3,500 |   |
| Vested              |   |          | 470,944 |   |                                 |   | 3.51   |                                         |   |   | 4.58                                        |   |   |                         | 2.33   |   |   |   | 3,500 |   |
| Nonvested           |   |          | 25,000  |   |                                 |   | 2.03   |                                         |   |   | 4.90                                        |   |   |                         | 0.68   |   |   |   | - |   |

----

| ●   | changes or advances in technology; |
|---------------------|------------------------------------|

| ●   | the success of our LMR product line; |
|---------------------|--------------------------------------|

| ●   | competition in the land mobile radio industry; |
|---------------------|------------------------------------------------|

| ●   | general economic and business conditions, including federal, state and local government budget deficits and spending limitations; |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------|

| ●   | the availability, terms and deployment of capital; |
|---------------------|----------------------------------------------------|

| ●   | reliance on contract manufacturers and suppliers; |
|---------------------|---------------------------------------------------|

| ●   | heavy reliance on sales to agencies of the United States government; |
|---------------------|----------------------------------------------------------------------|

| ●   | our ability to utilize deferred tax assets; |
|---------------------|---------------------------------------------|

| ●   | retention of executive officers and key personnel; |
|---------------------|----------------------------------------------------|

| ●   | our ability to manage our growth; |
|---------------------|-----------------------------------|

| ●   | government regulation; |
|---------------------|------------------------|

| ●   | our business with manufacturers located in other countries; |
|---------------------|-------------------------------------------------------------|

| ●   | our inventory and debt levels; |
|---------------------|--------------------------------|

| ●   | protection of our intellectual property rights; |
|---------------------|-------------------------------------------------|

| ●   | acts of war or terrorism; and |
|---------------------|-------------------------------|

| ●   | any infringement claims. |
|---------------------|--------------------------|

----

----

|                                         |   | Percentage of SalesThree Months Ended |   |   | Percentage of SalesSix Months Ended |   |
|----------------------------------------------|--------|---------------------------------------|--------|--------|-------------------------------------|--------|
|                                         |   | June 30,2012                          |   |   | June 30,2011                        |   |   | June 30,2012 |   |   | June 30,2011 |   |
|                                         |   |                                  |   |   |                                |   |   |   |   |   |   |   |
| Sales                                        |   |                                  | 100.0  | %      |                                |   | 100.0 | % |   |   | 100.0 | % |   |   | 100.0 | % |
| Cost of products                             |   |                                  | (50.3  | )      |                                |   | (64.5 | ) |   |   | (54.0 | ) |   |   | (62.6 | ) |
| Gross margin                                 |   |                                  | 49.7   |   |                                |   | 35.5 |   |   |   | 46.0 |   |   |   | 37.4 |   |
| Selling, general and administrative expenses |   |                                  | (28.1  | )      |                                |   | (53.2 | ) |   |   | (36.2 | ) |   |   | (50.3 | ) |
| Net interest -expense-                       |   |                                  | (0.0   | )      |                                |   | (0.6 | ) |   |   | (0.0 | ) |   |   | (0.5 | ) |
| Other expense-                               |   |                                  | (0.0   | )      |                                |   | 0.0 |   |   |   | (0.1 | ) |   |   | (0.1 | ) |
| Pretax  (loss) income              |   |                                  | 21.6   |   |                                |   | (18.3 | ) |   |   | 9.7 |   |   |   | (13.5 | ) |
| Income tax expense                           |   |                                  | (8.2   | )      |                                |   | (3.6 | ) |   |   | (3.6 | ) |   |   | (0.0 | ) |
| Net (loss) income                            |   |                                  | 13.4   | %      |                                |   | (6.2 | )% |   |   | 6.2 | % |   |   | (13.5 | )% |

----

----

----

----

----

| Exhibit 3(i)    | Articles of Incorporation(1)                                                                                                                                                      |
|-----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|            |                                                                                                                                                                              |
| Exhibit 3(ii)   | Certificate of Amendment to Articles of Incorporation(2)                                                                                                                          |
|            |                                                                                                                                                                              |
| Exhibit 3(iii)  | By-Laws, as amended (3)                                                                                                                                                           |
|            |                                                                                                                                                                              |
| Exhibit 31.1    | Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                |
|            |                                                                                                                                                                              |
| Exhibit 31.2    | Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                |
|            |                                                                                                                                                                              |
| Exhibit 32.1    | Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished pursuant to Item 601(b)(32) of Regulation S-K). |
|            |                                                                                                                                                                              |
| Exhibit 32.2    | Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished pursuant to Item 601(b)(32) of Regulation S-K). |
|            |                                                                                                                                                                              |
| Exhibit 101.INS | XBRL Instance Document*                                                                                                                                                           |
|            |                                                                                                                                                                              |
| Exhibit 101.SCH | XBRL Taxonomy Extension Schema Document*                                                                                                                                          |
|            |                                                                                                                                                                              |
| Exhibit 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document*                                                                                                                            |
|            |                                                                                                                                                                              |
| Exhibit 101.LAB | XBRL Taxonomy Extension Label Linkbase Document*                                                                                                                                  |
|            |                                                                                                                                                                              |
| Exhibit 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document*                                                                                                                           |
|            |                                                                                                                                                                              |
| Exhibit 101.DEF | XBRL Taxonomy Definition Linkbase Document*                                                                                                                                       |

| *  | Pursuant to Rule 405(a)(2) of Regulation S-T, the Company will furnish the XBRL Interactive Data Files with detailed footnote tagging as Exhibits 101.INS, 101.SCH, 101.CAL, 101.LAB, 101.PRE and 101.DEF in an amendment to this Form 10-Q within the permitted 30-day grace period for the first quarterly period in which detailed footnote tagging is required after the filing date of this Form 10-Q. |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (1) | Incorporated by reference from the Company's Annual Report on Form 10-K for the year ended December 31, 1997. |
|-----|---------------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2001. |
|-----|----------------------------------------------------------------------------------------------------------------------|

| (3) | Incorporated by reference to the Company's Registration Statement on Form S-3 (Registration No. 333-129113). |
|-----|--------------------------------------------------------------------------------------------------------------|

----

|                            | RELM WIRELESS CORPORATION      |                                                                                                                                                                                                                                                                                                                                                                                                                     |
|---------------------------------|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                            | (The “Registrant”) |                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                            |                           |                                                                                                                                                                                                                                                                                                                                                                                                                     |   |
| Date: August 8, 2012            | By:                            | /s/David P. Storey                                                                  |   |
|                            |                           | David P. StoreyPresident and Chief Executive Officer(Principal executive officer and duly authorized officer)                                                                                                                                                                                                                                                                                                       |   |
|                            |                           |                                                                                                                                                                                                                                                                                                                                                                                                                     |   |
|                            |                           |                                                                                                                                                                                                                                                                                                                                                                                                                     |   |
| Date:  August 8, 2012 | By:                            | /s/William P. Kelly                                                                      |   |
|                            |                           | William P. KellyExecutive Vice President and Chief Financial Officer(Principal financial and accounting officer and duly authorized officer)                                                                                                                                                                                                                                                                             |   |

----

| ExhibitNumber   |   | Description                                                                                                                                                                       |   |
|-----------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|            |   |                                                                                                                                                                              |   |
| Exhibit 3(i)    |   | Articles of Incorporation(1)                                                                                                                                                      |
|            |   |                                                                                                                                                                              |
| Exhibit 3(ii)   |   | Certificate of Amendment to Articles of Incorporation(2)                                                                                                                          |
|            |   |                                                                                                                                                                              |
| Exhibit 3(iii)  |   | By-Laws, as amended (3)                                                                                                                                                           |
|            |   |                                                                                                                                                                              |
| Exhibit 31.1    |   | Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                |
|            |   |                                                                                                                                                                              |
| Exhibit 31.2    |   | Certification Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.                                                |
|            |   |                                                                                                                                                                              |
| Exhibit 32.1    |   | Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished pursuant to Item 601(b)(32) of Regulation S-K). |
|            |   |                                                                                                                                                                              |
| Exhibit 32.2    |   | Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished pursuant to Item 601(b)(32) of Regulation S-K). |
|            |   |                                                                                                                                                                              |
| Exhibit 101.INS |   | XBRL Instance Document*                                                                                                                                                           |
|            |   |                                                                                                                                                                              |
| Exhibit 101.SCH |   | XBRL Taxonomy Extension Schema Document*                                                                                                                                          |
|            |   |                                                                                                                                                                              |
| Exhibit 101.CAL |   | XBRL Taxonomy Extension Calculation Linkbase Document*                                                                                                                            |
|            |   |                                                                                                                                                                              |
| Exhibit 101.LAB |   | XBRL Taxonomy Extension Label Linkbase Document*                                                                                                                                  |
|            |   |                                                                                                                                                                              |
| Exhibit 101.PRE |   | XBRL Taxonomy Extension Presentation Linkbase Document*                                                                                                                           |
|            |   |                                                                                                                                                                              |
| Exhibit 101.DEF |   | XBRL Taxonomy Definition Linkbase Document*                                                                                                                                       |

| *  | Pursuant to Rule 405(a)(2) of Regulation S-T, the Company will furnish the XBRL Interactive Data Files with detailed footnote tagging as Exhibits 101.INS, 101.SCH, 101.CAL, 101.LAB, 101.PRE and 101.DEF in an amendment to this Form 10-Q within the permitted 30-day grace period for the first quarterly period in which detailed footnote tagging is required after the filing date of this Form 10-Q. |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (1) | Incorporated by reference from the Company's Annual Report on Form 10-K for the year ended December 31, 1997. |
|-----|---------------------------------------------------------------------------------------------------------------|

| (2) | Incorporated by reference from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2001. |
|-----|----------------------------------------------------------------------------------------------------------------------|

| (3) | Incorporated by reference to the Company's Registration Statement on Form S-3 (Registration No. 333-129113). |
|-----|--------------------------------------------------------------------------------------------------------------|

----